Definium Therapeutics, Inc. ($DFTX)
Filing Information
| Accession Number | 0001193125-26-271155 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 15, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
18,175
Total Value
$0.00
P&L
+inf% (+$816,966.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Jun 11, 2026 | Grant/Award | 3,555 | $0.00 | $0.00 | 3,555 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Grant/Award | 14,620 | $0.00 | $0.00 | 14,620 | Direct | โ | View Details |